INOVIQ detects 19% more breast cancers than leading test
Filed with ASX · · 3 pages · English
Earlier from Inoviq
- Appendix 4C and Quarterly Activities Report - December 2023
- 2023 AGM CEO Presentation
- Bell Potter Healthcare Conference Investor Presentation
- ANSEV Meeting Presentations
- Appendix 4C and Quarterly Activities Report - September 2023
Later from Inoviq
- Appendix 4D and FY24 Half Year Financial Report
- INOVIQ and Promega sign Global EXO-NET Agreement
- INOVIQ Investor Update
- Ovarian Cancer Test Validation
- Quarterly Activities Report and Appendix 4C - March 2024
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq